Position in LLY
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$860,409,883
-$225,438,292 QoQ
Shares Held
935,462
-7.4% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
2.58%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026PARNASSUS INVESTMENTS, LLC holds $987,357,686 across 3 Drug Manufacturers - General names. LLY ranks #1 (87.1% of the industry book) .
All Filings in LLY
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $860,409,883 | 935,462 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,085,848,175 | 1,010,392 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $479,377,640 | 628,280 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $660,710,919 | 847,576 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $729,096,829 | 882,780 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $721,589,944 | 934,702 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,120,054 | 2,393 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,878,663 | 2,075 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,276,632 | 1,641 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $838,238 | 1,438 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $732,645 | 1,364 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $531,354 | 1,133 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $354,066 | 1,031 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $315,354 | 862 | Shares | Sole | 2023-01-30 | |
| No filing history on record for this holder in this stock. | ||||||